Self-harm is common among adolescents and a strong predictor of suicide risk. A major new cohort study in the British Journal of Psychiatry explores how genetic risk and brain differences might explain who’s most at risk, and why.
[read the full story...]
Single-session interventions represent a low-cost, one-off, scalable intervention that may help to bridge the treatment gap for mental health problems. But are they actually effective, and how do they compare to typical, multi-session interventions? This umbrella review indicates that they are an important tool to have in our toolbox of treatment options.
[read the full story...]
Non-communicable diseases cause 74% of global deaths. Could singing, dancing or storytelling really make a difference? This new review explores how arts-based interventions can boost public health worldwide.
[read the full story...]
Could years of commuting through city smog be leaving lasting marks on our brains? A major UK birth cohort study suggests that midlife exposure to nitrogen dioxide and other pollutants may lead to smaller hippocampal volumes and slower cognitive processing in later life, even after accounting for social and educational factors.
[read the full story...]
A large multicentre trial from Germany found that repetitive Transcranial Magnetic Stimulation (rTMS) significantly reduced auditory hallucinations compared to sham treatment. Could this safe and well-tolerated therapy finally offer new hope for people with persistent voices?
[read the full story...]
Not all childhood trauma has the same biological impact. A new study finds that adversity in late childhood is most strongly linked to immune dysregulation at age 24.
[read the full story...]
A large NHS trial found that the Circle of Security parenting programme did not outperform treatment-as-usual for parents experiencing perinatal mental health difficulties. But does this mean we should stop offering it?
[read the full story...]
Is teenage depression more likely to come back later in life? A new population study challenges assumptions and finds similar recurrence risks in both adolescents and adults.
[read the full story...]
How safe is it to treat ADHD in people with schizophrenia spectrum disorders? New long-term data offers pragmatic reassurance, but also some warnings.
[read the full story...]
Clozapine is described as the gold standard treatment for schizophrenia but a new cohort study suggests it is associated with an increased risk of infections, particularly in older patients, further solidifying the case for holistic care.
[read the full story...]
